Monitor for a successor appointment and any updates to the clinical development timeline; the absence of a named replacement or stated reason introduces moderate operational uncertainty for a clinical-stage biotech.
Price Chart
Executive Summary
Longeveron Inc. disclosed that Dr. Nataliya Agafonova stepped down as Chief Medical Officer, effective October 14, 2026. No replacement was named, and no reason (resignation, termination, retirement) was provided beyond her informing management of her decision.
Key Facts
- Dr. Nataliya Agafonova stepped down as Chief Medical Officer, effective October 14, 2026.
- No replacement was named in the filing.
- The filing does not state a reason (resignation, retirement, or termination) for the departure.
Financial Impact
No financial impact disclosed; departure of a senior clinical officer may slow pipeline execution but no material costs or savings stated.
Risk Factors
- Potential delay in clinical programs if a new CMO is not appointed promptly.
- Lack of stated reason could signal internal discord or dissatisfaction, though no evidence of broader C-suite instability.
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001213900-26-109411 |
| Document: 0001213900-26-109411-index-headers.html | 0001213900-26-109411 |
| Document: 0001213900-26-109411-index.html | 0001213900-26-109411 |
| Document: 0001213900-26-109411.txt | 0001213900-26-109411 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 1d ago | 8-K | $1.61 | awaiting T+60 | — | $1.73 (+7.79%) |
Oct 26, 2026 1d ago | Press Release | $1.61 | awaiting T+60 | — | $1.73 (+7.79%) |
Oct 14, 2026 13d ago | 8-K | $1.50 | awaiting T+60 | — | $1.73 (+15.33%) |
Sep 16, 2026 5w ago | Press Release | $2.71 | awaiting T+60 | — | $1.73 (+36.16%) |
Sep 14, 2026 6w ago | 8-K | $6.86 | awaiting T+60 | — | $1.73 (−74.78%) |
Jul 13, 2026 15w ago | 3 | $0.6223 $0.2440 | ▼ −60.79% | ▼ −64.17% | $1.73 (+178.00%) |
Jun 5, 2026 20w ago | 8-K | $0.7540 $0.6780 | ▼ −10.08% | ▼ −13.59% | $1.73 (+129.44%) |
May 20, 2026 22w ago | Press Release | $0.7210 $0.8200 | ▲ +13.73% | ▲ +9.43% | $1.73 (+139.94%) |
May 13, 2026 23w ago | 8-K | $0.7030 $0.7363 | ▲ +4.74% | ▲ +1.15% | $1.73 (+146.09%) |
May 8, 2026 24w ago | 8-K | $0.8380 $0.7271 | ▲ +13.23% | ▲ +17.63% | $1.73 (−106.44%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers